IL17A and neoplasm: In addition to the pathways refered by the GSEA, we have a specific look on those pathways that are important for an anti-tumor immune response, such as T-cell receptor signaling (Figures 4C, D), B-cell receptor signaling (Supplementary Figure 2A), NK cell–mediated toxicity (Supplementary Figure 2B), leucocyte transendothelial migration pathways (Supplementary Figure 3A), and IL-17 signaling (Supplementary Figures 1B, 3B).